Stocks · Health care · Pharmaceutical Preparations

UroGen Pharma Ltd.

URGN Clue Score39
Israel Fiscal year ends December CIK 0001668243 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Chris Degnan
8 Oct 2026
Chief Financial Officer
Sold after exercise
2,202
$36.69
$80.79K
Mark Schoenberg
8 Jun 2026
Chief Medical Officer
Sold after exercise
5,222
$27.30
$142.56K

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 2
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 62,317
History held since 29 Nov 2017